{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:16:23Z","timestamp":1793654183453,"version":"4.5.1"},"reference-count":176,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL136135"],"award-info":[{"award-number":["R01 HL136135"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL151765"],"award-info":[{"award-number":["R01 HL151765"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U19 HL156247"],"award-info":[{"award-number":["U19 HL156247"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI135953"],"award-info":[{"award-number":["R01 AI135953"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI138329"],"award-info":[{"award-number":["U01 AI138329"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI149505"],"award-info":[{"award-number":["U19 AI149505"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI149680"],"award-info":[{"award-number":["U19 AI149680"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI126623"],"award-info":[{"award-number":["UM1 AI126623"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ymthe.2021.09.026","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T02:53:14Z","timestamp":1633056794000},"page":"3140-3152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Genome editing in large animal models"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-6755","authenticated-orcid":false,"given":"Lucy H.","family":"Maynard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3215-8924","authenticated-orcid":false,"given":"Christopher W.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5949-4947","authenticated-orcid":false,"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.09.026_bib1","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.09.026_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10875-012-9844-3","article-title":"Critical differences in hematopoiesis and lymphoid development between humans and mice","volume":"33","author":"Parekh","year":"2013","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib3","first-page":"4227","article-title":"Clinical predictive value of the in\u00a0vitro cell line, human xenograft, and mouse allograft preclinical cancer models","volume":"9","author":"Voskoglou-Nomikos","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2021.09.026_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/483531a","article-title":"Drug development: Raise standards for preclinical cancer research","volume":"483","author":"Begley","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.026_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.14573\/altex.1310071","article-title":"Animal models of Alzheimer disease: historical pitfalls and a path forward","volume":"31","author":"Cavanaugh","year":"2014","journal-title":"ALTEX"},{"key":"10.1016\/j.ymthe.2021.09.026_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2006.12.015","article-title":"Lost in translation: treatment trials in the SOD1 mouse and in human ALS","volume":"26","author":"Benatar","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2021.09.026_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nri1502","article-title":"Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes","volume":"4","author":"Roep","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib8","doi-asserted-by":"crossref","first-page":"e1000245","DOI":"10.1371\/journal.pmed.1000245","article-title":"Can animal models of disease reliably inform human studies?","volume":"7","author":"van der Worp","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib9","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.2741\/2434","article-title":"The importance of large animal models in transplantation","volume":"12","author":"Dehoux","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ymthe.2021.09.026_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tim.2011.11.002","article-title":"The pig: a model for human infectious diseases","volume":"20","author":"Meurens","year":"2012","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing","volume":"49","author":"Swindle","year":"2012","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajp.22281","article-title":"Why primate models matter","volume":"76","author":"Phillips","year":"2014","journal-title":"Am. J. Primatol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cbf.3173","article-title":"Large animal models of cardiovascular disease","volume":"34","author":"Tsang","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ymthe.2021.09.026_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.reprotox.2019.06.005","article-title":"Comparison of immune system development in nonclinical species and humans: Closing information gaps for immunotoxicity testing and human translatability","volume":"89","author":"Skaggs","year":"2019","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib15","article-title":"Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques","author":"AlJanahi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib16","first-page":"11","article-title":"Canine models of bone marrow transplantation","volume":"40","author":"Ladiges","year":"1990","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.ymthe.2021.09.026_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00335-004-3047-z","article-title":"IDID: inherited diseases in dogs: web-based information for canine inherited disease genetics","volume":"15","author":"Sargan","year":"2004","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.ymthe.2021.09.026_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molmed.2011.02.004","article-title":"Dog models of naturally occurring cancer","volume":"17","author":"Rowell","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib19","first-page":"E30","article-title":"Large mammalian animal models of heart disease","volume":"3","author":"Camacho","year":"2016","journal-title":"J.\u00a0Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.ymthe.2021.09.026_bib20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/gt.2010.47","article-title":"Large animal models of hematopoietic stem cell gene therapy","volume":"17","author":"Trobridge","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12977-020-00516-2","article-title":"Benefits and limitations of humanized mice in HIV persistence studies","volume":"17","author":"Marsden","year":"2020","journal-title":"Retrovirology"},{"key":"10.1016\/j.ymthe.2021.09.026_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tig.2007.03.001","article-title":"The challenge of modeling macular degeneration in mice","volume":"23","author":"Marmorstein","year":"2007","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nrmicro2911","article-title":"Animal models for HIV\/AIDS research","volume":"10","author":"Hatziioannou","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib24","first-page":"255","article-title":"Nonhuman primate models in AIDS research","volume":"8","author":"Evans","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.ymthe.2021.09.026_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2021.09.026_bib26","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.09.026_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/156652311794520111","article-title":"Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy","volume":"11","author":"Silva","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/protein\/gzq083","article-title":"The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy","volume":"24","author":"Arnould","year":"2011","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ymthe.2021.09.026_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3486","article-title":"TALENs: a widely applicable technology for targeted genome editing","volume":"14","author":"Joung","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.026_bib31","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2021.09.026_bib32","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.026_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2021.09.026_bib34","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1126\/science.1079512","article-title":"Enhancing gene targeting with designed zinc finger nucleases","volume":"300","author":"Bibikova","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.026_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/hiv.12421","article-title":"Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis","volume":"18","author":"Teeraananchai","year":"2017","journal-title":"HIV Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib36","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.026_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/44755","article-title":"Re-emergence of HIV after stopping therapy","volume":"401","author":"Chun","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.026_bib38","doi-asserted-by":"crossref","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T\u00a0cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.09.026_bib39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm.4108","article-title":"International AIDS Society global scientific strategy: towards an HIV cure 2016","volume":"22","author":"Deeks","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib41","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5\u039432\/\u039432 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.026_bib42","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2352-3018(20)30069-2","article-title":"Evidence for HIV-1 cure after CCR5\u039432\/\u039432 allogeneic haemopoietic stem-cell transplantation 30\u00a0months post analytical treatment interruption: a case report","volume":"7","author":"Gupta","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ymthe.2021.09.026_bib43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0092-8674(00)80577-2","article-title":"Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry","volume":"96","author":"Farzan","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.09.026_bib44","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3389\/fmicb.2020.00882","article-title":"Toward a macaque model of HIV-1 infection: Roadblocks, progress, and future strategies","volume":"11","author":"Thippeshappa","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib45","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41467-021-21389-9","article-title":"Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19","volume":"12","author":"Salguero","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.026_bib46","doi-asserted-by":"crossref","first-page":"e14019","DOI":"10.1371\/journal.pone.0014019","article-title":"Evolution of the antiretroviral restriction factor TRIMCyp in Old World primates","volume":"5","author":"Dietrich","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.09.026_bib47","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1128\/JVI.02499-06","article-title":"Novel TRIM5 isoforms expressed by Macaca nemestrina","volume":"81","author":"Brennan","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib48","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.exphem.2013.04.014","article-title":"Efficient transduction of human hematopoietic repopulating cells with a chimeric HIV1-based vector including SIV capsid","volume":"41","author":"Uchida","year":"2013","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/mt.2013.256","article-title":"TRIM5\u03b1 variations influence transduction efficiency with lentiviral vectors in both human and rhesus CD34(+) cells in\u00a0vitro and in\u00a0vivo","volume":"22","author":"Evans","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib50","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood-2004-01-0045","article-title":"Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system","volume":"103","author":"Hanawa","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.026_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ilar\/ilt036","article-title":"Haplessly hoping: macaque major histocompatibility complex made easy","volume":"54","author":"Wiseman","year":"2013","journal-title":"ILAR J."},{"key":"10.1016\/j.ymthe.2021.09.026_bib52","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2015-09-672337","article-title":"Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates","volume":"127","author":"Peterson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.026_bib53","doi-asserted-by":"crossref","first-page":"e1006956","DOI":"10.1371\/journal.ppat.1006956","article-title":"Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy","volume":"14","author":"Peterson","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2021.09.026_bib54","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.omtm.2020.03.004","article-title":"Experimental treatment of SIV-infected macaques via autograft of CCR5-disrupted hematopoietic stem and progenitor cells","volume":"17","author":"Yu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.026_bib55","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.2020006372","article-title":"Robust expansion of HIV CAR T\u00a0cells following antigen boosting in ART-suppressed nonhuman primates","volume":"136","author":"Rust","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.026_bib56","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41467-020-19821-7","article-title":"CRISPR based editing of SIV proviral DNA in ART treated non-human primates","volume":"11","author":"Mancuso","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.026_bib57","doi-asserted-by":"crossref","first-page":"100247","DOI":"10.1016\/j.xcrm.2021.100247","article-title":"Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models","volume":"2","author":"Uchida","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.omtm.2017.11.005","article-title":"A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for \u03b2-Hemoglobinopathies","volume":"8","author":"Humbert","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2021.09.026_bib59","doi-asserted-by":"crossref","first-page":"eaaw3768","DOI":"10.1126\/scitranslmed.aaw3768","article-title":"Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates","volume":"11","author":"Humbert","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib60","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1172\/JCI140189","article-title":"BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicity","volume":"130","author":"Demirci","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.09.026_bib61","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T\u00a0cell immunotherapy for acute myeloid leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.09.026_bib62","doi-asserted-by":"crossref","first-page":"e8647","DOI":"10.1371\/journal.pone.0008647","article-title":"A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping","volume":"5","author":"Walmsley","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.09.026_bib63","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.026_bib64","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1093\/hmg\/ddt287","article-title":"Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle","volume":"22","author":"Klymiuk","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","article-title":"Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy","volume":"26","author":"Moretti","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib66","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nbt.4182","article-title":"Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol","volume":"36","author":"Wang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib67","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.ymthe.2021.02.020","article-title":"Long-term stable reduction of low-density lipoprotein in nonhuman primates following in\u00a0vivo genome editing of PCSK9","volume":"29","author":"Wang","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib68","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In\u00a0vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.026_bib69","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In\u00a0vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib71","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/hum.2018.193","article-title":"Somatic gene editing of GUCY2D by AAV-CRISPR\/Cas9 alters retinal structure and function in mouse and macaque","volume":"30","author":"McCullough","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib72","doi-asserted-by":"crossref","first-page":"e57646","DOI":"10.7554\/eLife.57646","article-title":"Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation","volume":"10","author":"Cardozo-Ojeda","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2021.09.026_bib73","doi-asserted-by":"crossref","first-page":"e1004406","DOI":"10.1371\/journal.ppat.1004406","article-title":"Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant","volume":"10","author":"Mavigner","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2021.09.026_bib74","doi-asserted-by":"crossref","first-page":"e91230","DOI":"10.1172\/jci.insight.91230","article-title":"Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation","volume":"2","author":"Peterson","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2021.09.026_bib75","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1038\/s41467-018-06736-7","article-title":"Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation","volume":"9","author":"Colonna","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.026_bib76","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T\u00a0cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib77","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib78","doi-asserted-by":"crossref","first-page":"144486","DOI":"10.1172\/JCI144486","article-title":"CCR5-edited CD4+ T\u00a0cells augment HIV-specific immunity to enable post-rebound control of HIV replication","volume":"131","author":"Tebas","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.09.026_bib79","article-title":"Infusion of CCR5 gene-edited T\u00a0cells allows immune reconstitution, HIV reservoir decay, and long-term virological control","author":"Zeidan","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2021.09.026_bib80","doi-asserted-by":"crossref","first-page":"307ra156","DOI":"10.1126\/scitranslmed.aac5530","article-title":"Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template","volume":"7","author":"Sather","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib81","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ymthe.2016.12.023","article-title":"Engineering HIV-resistant, anti-HIV chimeric antigen receptor T\u00a0cells","volume":"25","author":"Hale","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib82","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1038\/ncomms15464","article-title":"CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome","volume":"8","author":"Shin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.026_bib83","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1038\/s41467-019-13007-6","article-title":"Highly efficient multiplex human T\u00a0cell engineering without double-strand breaks using Cas9 base editors","volume":"10","author":"Webber","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.026_bib84","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.026_bib85","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ymthe.2021.09.026_bib86","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2021.09.026_bib87","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease","volume":"340","author":"Steinberg","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","article-title":"Beta-thalassemia","volume":"12","author":"Cao","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib89","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene therapy in a patient with sickle cell disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib90","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene Therapy in Patients with Transfusion-Dependent \u03b2-Thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib91","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.09.026_bib92","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1073\/pnas.092027799","article-title":"Differential regulation of the human and murine CD34 genes in hematopoietic stem cells","volume":"99","author":"Okuno","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl 2","key":"10.1016\/j.ymthe.2021.09.026_bib93","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1093\/infdis\/jit319","article-title":"Overcoming current limitations in humanized mouse research","volume":"208","author":"Brehm","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2021.09.026_bib94","first-page":"46","article-title":"In\u00a0vivo HSC gene therapy for hemoglobinopathies: A proof of concept evaluation in rhesus macaques","volume":"136","author":"Li","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.026_bib95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/hum.2020.263","article-title":"Safe and effective in\u00a0vivo targeting and gene editing in hematopoietic stem cells: strategies for accelerating development","volume":"32","author":"Cannon","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib96","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood-2014-12-615948","article-title":"Correction of the sickle cell disease mutation in human hematopoietic stem\/progenitor cells","volume":"125","author":"Hoban","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.026_bib97","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/mt.2016.148","article-title":"CRISPR\/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells","volume":"24","author":"Hoban","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib98","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/stem.2935","article-title":"Improving gene editing outcomes in human hematopoietic stem and progenitor cells by temporal control of DNA repair","volume":"37","author":"Lomova","year":"2019","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2021.09.026_bib99","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1093\/nar\/gkz475","article-title":"Highly efficient editing of the \u03b2-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease","volume":"47","author":"Park","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.09.026_bib100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.1998.tb10460.x","article-title":"Molecular basis of hereditary persistence of fetal hemoglobin","volume":"850","author":"Forget","year":"1998","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.ymthe.2021.09.026_bib101","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood-2011-09-382408","article-title":"Fetal hemoglobin levels and morbidity in untransfused patients with \u03b2-thalassemia intermedia","volume":"119","author":"Musallam","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.026_bib102","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.026_bib103","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1093\/nar\/16.22.10635","article-title":"Distal CCAAT box deletion in the A gamma globin gene of two black adolescents with elevated fetal A gamma globin","volume":"16","author":"Gilman","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.09.026_bib104","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.celrep.2016.08.064","article-title":"Bcl11a deficiency leads to hematopoietic stem cell defects with an aging-like phenotype","volume":"16","author":"Luc","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2021.09.026_bib105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ni925","article-title":"Bcl11a is essential for normal lymphoid development","volume":"4","author":"Liu","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib106","doi-asserted-by":"crossref","first-page":"E998","DOI":"10.1073\/pnas.1319228111","article-title":"Dendritic cell fate is determined by BCL11A","volume":"111","author":"Ippolito","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.09.026_bib107","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1126\/science.1242088","article-title":"An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level","volume":"342","author":"Bauer","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.09.026_bib108","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","article-title":"Highly efficient therapeutic gene editing of human hematopoietic stem cells","volume":"25","author":"Wu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib109","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib110","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib112","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(20)31366-0","article-title":"Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study","volume":"396","author":"Abramson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2021.09.026_bib113","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma","volume":"382","author":"Wang","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib114","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene vicleucel in relapsed and refractory multiple myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib115","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1158\/2159-8290.CD-17-1368","article-title":"Chimeric antigen receptor T\u00a0cell-mediated neurotoxicity in nonhuman primates","volume":"8","author":"Taraseviciute","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2021.09.026_bib116","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/bcj.2014.39","article-title":"Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia","volume":"4","author":"Ehninger","year":"2014","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ymthe.2021.09.026_bib117","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2005-03-1072","article-title":"Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia","volume":"106","author":"Taussig","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.09.026_bib118","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1128\/MCB.23.12.4199-4206.2003","article-title":"CD33\/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice","volume":"23","author":"Brinkman-Van der Linden","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib119","doi-asserted-by":"crossref","first-page":"11978","DOI":"10.1073\/pnas.1819992116","article-title":"Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies","volume":"116","author":"Borot","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.09.026_bib120","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib121","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2021.09.026_bib122","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.09.026_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2021.09.026_bib124","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2021.09.026_bib125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmedgenet-2015-103387","article-title":"The importance of genetic diagnosis for Duchenne muscular dystrophy","volume":"53","author":"Aartsma-Rus","year":"2016","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib126","doi-asserted-by":"crossref","first-page":"eaan8081","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib127","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nbt.3816","article-title":"Highly efficient RNA-guided base editing in mouse embryos","volume":"35","author":"Kim","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib128","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ymthe.2018.03.018","article-title":"Functional rescue of dystrophin deficiency in mice caused by frameshift mutations using Campylobacter jejuni Cas9","volume":"26","author":"Koo","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib129","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1038\/s41467-019-12335-x","article-title":"In\u00a0vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse","volume":"10","author":"Amoasii","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.026_bib130","doi-asserted-by":"crossref","first-page":"dmm037655","DOI":"10.1242\/dmm.037655","article-title":"CRISPR\/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene","volume":"12","author":"Egorova","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2021.09.026_bib131","doi-asserted-by":"crossref","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2021.09.026_bib132","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ymthe.2020.05.024","article-title":"Correction of three prominent mutations in mouse and human models of Duchenne muscular dystrophy by single-cut genome editing","volume":"28","author":"Min","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib133","doi-asserted-by":"crossref","first-page":"e110371","DOI":"10.1371\/journal.pone.0110371","article-title":"Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy","volume":"9","author":"Larcher","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.09.026_bib134","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1038\/srep05635","article-title":"Generation of muscular dystrophy model rats with a CRISPR\/Cas system","volume":"4","author":"Nakamura","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2021.09.026_bib135","doi-asserted-by":"crossref","first-page":"dmm032201","DOI":"10.1242\/dmm.032201","article-title":"A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR\/Cas9","volume":"11","author":"Sui","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2021.09.026_bib136","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1038\/s41467-019-10421-8","article-title":"Efficient base editing for multiple genes and loci in pigs using base editors","volume":"10","author":"Xie","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.09.026_bib137","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1093\/hmg\/ddv120","article-title":"Functional disruption of the dystrophin gene in rhesus monkey using CRISPR\/Cas9","volume":"24","author":"Chen","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib138","first-page":"179","article-title":"Optimizing exon skipping therapies for DMD","volume":"26","author":"Yokota","year":"2007","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib139","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1093\/hmg\/ddv155","article-title":"How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse","volume":"24","author":"Godfrey","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2014.01.009","article-title":"Low dystrophin levels in heart can delay heart failure in mdx mice","volume":"69","author":"van Putten","year":"2014","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib141","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split-Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.09.026_bib142","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.09.026_bib143","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1073\/pnas.0409736102","article-title":"Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment","volume":"102","author":"Maxwell","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.09.026_bib144","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib145","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib146","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib147","doi-asserted-by":"crossref","first-page":"e001632","DOI":"10.1161\/CIRCGENETICS.116.001632","article-title":"PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites","volume":"10","author":"Kent","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib148","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib149","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.09.026_bib150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12864-020-6655-4","article-title":"ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in\u00a0vivo following adeno-associated viral vector-mediated genome editing","volume":"21","author":"Breton","year":"2020","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ymthe.2021.09.026_bib151","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"Gaudelli","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib152","article-title":"Global-scale CRISPR gene editor specificity profiling by ONE-seq identifies population-specific, variant off-target effects","author":"Petri","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2021.09.026_bib153","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib154","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/hum.2020.231","article-title":"Genome-editing strategies for treating human retinal degenerations","volume":"32","author":"Quinn","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.preteyeres.2010.03.004","article-title":"The molecular basis of human retinal and vitreoretinal diseases","volume":"29","author":"Berger","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2021.09.026_bib156","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2021.09.026_bib157","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI123980","article-title":"A nonhuman primate model of inherited retinal disease","volume":"129","author":"Moshiri","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.09.026_bib158","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.survophthal.2004.04.003","article-title":"An overview of Leber congenital amaurosis: a model to understand human retinal development","volume":"49","author":"Koenekoop","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib159","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ajo.2007.08.022","article-title":"Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture","volume":"144","author":"Stone","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/mgme.1999.2906","article-title":"Leber congenital amaurosis","volume":"68","author":"Perrault","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2021.09.026_bib161","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.preteyeres.2008.05.003","article-title":"Leber congenital amaurosis: genes, proteins and disease mechanisms","volume":"27","author":"den Hollander","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2021.09.026_bib162","doi-asserted-by":"crossref","first-page":"112","DOI":"10.12998\/wjcc.v3.i2.112","article-title":"Review and update on the molecular basis of Leber congenital amaurosis","volume":"3","author":"Chacon-Camacho","year":"2015","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.ymthe.2021.09.026_bib163","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/507318","article-title":"Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis","volume":"79","author":"den Hollander","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib164","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0042-6989(93)90144-L","article-title":"Assessment of foveal cone photoreceptors in Stargardt\u2019s macular dystrophy using a small dot detection task","volume":"33","author":"Geller","year":"1993","journal-title":"Vision Res."},{"key":"10.1016\/j.ymthe.2021.09.026_bib165","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jmg.38.9.611","article-title":"Clustering and frequency of mutations in the retinal guanylate cyclase (GUCY2D) gene in patients with dominant cone-rod dystrophies","volume":"38","author":"Payne","year":"2001","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ymthe.2021.09.026_bib166","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1167\/iovs.08-1901","article-title":"Mutation analysis identifies GUCY2D as the major gene responsible for autosomal dominant progressive cone degeneration","volume":"49","author":"Kitiratschky","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2021.09.026_bib167","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0161-6420(99)00038-X","article-title":"Autosomal dominant cone-rod retinal dystrophy (CORD6) from heterozygous mutation of GUCY2D, which encodes retinal guanylate cyclase","volume":"107","author":"Gregory-Evans","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2021.09.026_bib168","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/scrt171","article-title":"Large animal models for stem cell therapy","volume":"4","author":"Harding","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib169","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1039\/b819201d","article-title":"Microscale electroporation: challenges and perspectives for clinical applications","volume":"1","author":"Lee","year":"2009","journal-title":"Integr. Biol."},{"key":"10.1016\/j.ymthe.2021.09.026_bib170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.stem.2019.04.010","article-title":"Lessons from London and Berlin: Designing a scalable gene therapy approach for HIV cure","volume":"24","author":"Peterson","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2021.09.026_bib171","first-page":"91","article-title":"In\u00a0vivo HSC gene therapy with high-level, erythroid-specific expression of a secreted SARS-CoV-2 decoy receptor (abstract)","volume":"29","author":"Wang","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib172","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ymthe.2020.09.001","article-title":"In\u00a0Vivo HSC Gene Therapy Using a Bi-modular HDAd5\/35++ Vector Cures Sickle Cell Disease in a Mouse Model","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2021.09.026_bib173","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ymthe.2021.09.026_bib174","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/1873-3468.13668","article-title":"Adenovirus vectors in hematopoietic stem cell genome editing","volume":"593","author":"Li","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2021.09.026_bib175","doi-asserted-by":"crossref","first-page":"eabc9450","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2021.09.026_bib176","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41551-019-0357-8","article-title":"Adenine base editing in an adult mouse model of tyrosinaemia","volume":"4","author":"Song","year":"2020","journal-title":"Nat. Biomed. Eng."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621004810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621004810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T18:54:22Z","timestamp":1714589662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001621004810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":176,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1525001621004810"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.09.026","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome editing in large animal models","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021","name":"copyright","label":"Copyright"}]}}